Rosalie Pacula

Title(s)Professor
SchoolUSC Sol Price School of Public Policy
Address650 Childs Way
University Park Campus
Los Angeles CA 90089
Phone+1 213 821 8887
vCardDownload vCard
    Other Positions
    Title(s)Elizabeth Garrett Chair in Health Policy, Economics, and Law


    Collapse Research 
    Collapse Research Activities and Funding
    Impact of Marijuana Legalization on Opioid Prescribing and Poisonings in Colorado
    NIH R01DA045051Jul 15, 2018 - Mar 31, 2021
    Role: Principal Investigator
    The RAND Alcohol Policy Platform (RAPP): A Microsimulation Model of Alcohol Use, Consequences, and Policies in the United States
    NIH R01AA022132May 15, 2014 - Apr 30, 2021
    Role: Principal Investigator
    American Society of Health Economists
    NIH R13DA037684Apr 1, 2014 - Mar 31, 2015
    Role: Co-Principal Investigator
    Implementation of Medical Marijuana and its Impact on Health
    NIH R01DA032693Sep 15, 2011 - Aug 31, 2016
    Role: Principal Investigator
    ECONOMIC COST OF DRUG USE AND ABUSE
    NIH R01DA019993May 10, 2006 - Apr 30, 2011
    Role: Principal Investigator
    ARE THERE ECONOMIC COSTS OF MARIJUANA USE?
    NIH R01DA012724Feb 10, 2000 - Jul 31, 2008
    Role: Principal Investigator
    DEVELOPMENT OF DEMAND FOR INTOXICATING SUBSTANCES
    NIH F31AA005367Jan 30, 1994
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Association of Local Cannabis Policy and Retail Availability With Cannabis Use and Problematic Cannabis Use Among Adolescents in Northern California. Am J Public Health. 2024 Nov; 114(S8):S654-S663. Young-Wolff KC, Asera A, Padon AA, Slama NE, Alexeeff SE, Pacula RL, Campbell CI, Sterling SA, Satre DD, Lu Y, Dyer WT, Does MB, Silver LD. PMID: 39442032.
      View in: PubMed   Mentions:
    2. Medical Cannabis Dosing Trajectories of Patients: Evidence From Sales Data. Clin Ther. 2024 Oct 05. Kritikos AF, Graham M, Hodgkin D, Pacula RL. PMID: 39370328.
      View in: PubMed   Mentions:    Fields:    
    3. The association between state cannabis policies and cannabis use among adults and youth, United States, 2002-2019. Addiction. 2024 Sep 19. Pessar SC, Smart R, Naimi T, Lira M, Blanchette J, Boustead A, Pacula RL. PMID: 39300729.
      View in: PubMed   Mentions:    Fields:    
    4. Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization. JAMA Netw Open. 2024 Sep 03; 7(9):e2435478. Axeen S, Pacula RL, Merlin JS, Gordon AJ, Stein BD. PMID: 39320889; PMCID: PMC11425142.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Investigating the complexity of naloxone distribution: Which policies matter for pharmacies and potential recipients. J Health Econ. 2024 Sep; 97:102917. Smart R, Powell D, Pacula RL, Peet E, Abouk R, Davis CS. PMID: 39043099; PMCID: PMC11392605.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. The Impact of Medicaid Institutions for Mental Disease Exclusion Waivers on the Availability of Substance Abuse Treatment Services and the Varying Effect by Ownership Type. Milbank Q. 2024 Jul 05. Ge Y, Romley JA, Pacula RL. PMID: 38966909.
      View in: PubMed   Mentions:    Fields:    
    7. Conceptual Confusion Leads Policy Evaluation Astray. JAMA Health Forum. 2024 May 03; 5(5):e241180. Burris S, Pacula RL, Wagenaar AC. PMID: 38787542.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Relationships Between Alcohol and Cannabis Policies in U.S. States, 1999-2019. J Stud Alcohol Drugs. 2024 Mar; 85(2):254-260. Naimi TS, Lira MC, Pessar SC, Smart R, Blanchette J, Pacula RL. PMID: 38147075; PMCID: PMC10941819.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    9. Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process. J Addict Med. 2024 Mar-Apr 01; 18(2):129-137. Grant S, Smart R, Gordon AJ, Pacula RL, Stein BD. PMID: 38039084; PMCID: PMC10939945.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. America's Opioid Ecosystem: How Leveraging System Interactions Can Help Curb Addiction, Overdose, and Other Harms. Rand Health Q. 2023 Sep; 10(4):1. Stein BD, Kilmer B, Taylor J, Vaiana ME, Barnes-Proby D, Caulkins JP, Davis LM, Dworsky M, Gates SM, Iguchi MY, Osilla KC, Pacula RL, Pardo B, Sherry TB, Smucker S. PMID: 37720068; PMCID: PMC10501822.
      View in: PubMed   Mentions: 5  
    11. How to interpret studies on the impact of legalizing cannabis. Addiction. 2023 11; 118(11):2242-2243. Manthey J, Armstrong MJ, Hayer T, Myran DT, Pacula RL, Queirolo R, Rehm J, Wirth M, Zobel F. PMID: 37544768.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    12. Understanding the rise in overdose deaths involving opioids and non-opioid prescription drugs in the United States. Int J Drug Policy. 2023 Jul 06; 104104. Powell D, Peet ED, Pacula RL. PMID: 37422359; PMCID: PMC10770297.
      View in: PubMed   Mentions:    Fields:    
    13. Impact of Recreational Cannabis Legalization on Opioid Prescribing and Opioid-Related Hospital Visits in Colorado: an Observational Study. J Gen Intern Med. 2023 09; 38(12):2726-2733. Buttorff C, Wang GS, Wilks A, Tung G, Kress A, Schwam D, Pacula RL. PMID: 37340250; PMCID: PMC10506996.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    14. Medical marijuana access and prolonged opioid use among adolescents and young adults. Am J Addict. 2023 09; 32(5):479-487. Kim K, Pacula RL, Dick AW, Stein BD, Druss BG, Agbese E, Cohrs AC, Leslie DL. PMID: 37291067; PMCID: PMC10686234.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    15. Las 'Guías para el Uso de Cannabis de Menor Riesgo (GUCMR)': RECOMENDACIONES [The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (SPANISH)]. Int J Drug Policy. 2023 Apr 11; 103996. Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula R, Rehm J, Room R, van den Brink W, Hall W. PMID: 37055340.
      View in: PubMed   Mentions:    Fields:    
    16. Les 'Lignes Directrices Pour l'Usage du Cannabis à Moindre Risque (LUCMR)': RECOMMENDATIONS [The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (FRENCH)]. Int J Drug Policy. 2023 Apr 11; 103994. Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula R, Rehm J, Room R, van den Brink W, Hall W. PMID: 37055339.
      View in: PubMed   Mentions:    Fields:    
    17. Die 'Richtlinien für die Risiko-Reduzierung beim Cannabiskonsum (RRRCK)': EMPFEHLUNGEN[The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (GERMAN)]. Int J Drug Policy. 2023 Mar 24; 103995. Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula R, Rehm J, Room R, van den Brink W, Hall W. PMID: 36967339.
      View in: PubMed   Mentions:    Fields:    
    18. Regular Cannabis Use During the First Year of the Pandemic: Studying Trajectories Rather Than Prevalence. Am J Prev Med. 2023 06; 64(6):888-892. Lee JO, Lee WJ, Kritikos AF, Jin H, Leventhal AM, Pedersen ER, Cho J, Davis JP, Kapteyn A, Wilson JP, Pacula RL. PMID: 36805369; PMCID: PMC10200732.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsPHPublic Health
    19. The Cannabis Policy Scale: A New Research and Surveillance Tool for U.S. States. J Stud Alcohol Drugs. 2022 11; 83(6):829-838. Blanchette JG, Pacula RL, Smart R, Lira MC, Pessar SC, Naimi TS. PMID: 36484580; PMCID: PMC9756403.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    20. Most recent, modal, or median heroin purchase: Does it matter when estimating market size? Drug Alcohol Depend. 2022 12 01; 241:109667. Olmstead TA, Pacula RL, Alessi SM, Scott J. PMID: 36306700.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder. JAMA Health Forum. 2022 09 02; 3(9):e223285. Smart R, Grant S, Gordon AJ, Pacula RL, Stein BD. PMID: 36218944; PMCID: PMC10041351.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada. JAMA Netw Open. 2022 09 01; 5(9):e2231937. Myran DT, Roberts R, Pugliese M, Taljaard M, Tanuseputro P, Pacula RL. PMID: 36112372; PMCID: PMC9482056.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsPHPublic Health
    23. Spatial and temporal trends in the diagnosis of opioid-related problems in commercially-insured adolescents and young adults. Prev Med. 2022 10; 163:107194. Cohrs AC, Husnul Khotimah DE, Dick AW, Stein BD, Pacula RL, Druss BG, Kim K, Leslie DL. PMID: 35970406; PMCID: PMC10654710.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018. JAMA Health Forum. 2022 08 05; 3(8):e222663. Peet ED, Powell D, Pacula RL. PMID: 36200636; PMCID: PMC9391964.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    25. Characterization of Cannabis Products Purchased for Medical Use in New York State. JAMA Netw Open. 2022 08 01; 5(8):e2227735. Kritikos AF, Pacula RL. PMID: 35984662; PMCID: PMC9391960.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    26. California Cannabis Markets-Why Industry-Friendly Regulation Is Not Good Public Health. JAMA Health Forum. 2022 07 01; 3(7):e222018. Young-Wolff KC, Pacula RL, Silver LD. PMID: 36219000.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsPHPublic Health
    27. The iCannTookit: a consensus-based, flexible framework for measuring contemporary cannabis use. Addiction. 2022 09; 117(9):2558-2560. Lorenzetti V, Hindocha C, Petrilli K, Griffiths P, Brown J, Castillo-Carniglia Á, Caulkins JP, Englund A, El Sohly MA, Gage SH, Groshkova T, Gual A, Hammond D, Lawn W, López-Pelayo H, Manthey J, Mokrysz C, Liccardo Pacula R, van Laar M, Vandrey R, Wadsworth E, Winstock A, Hall W, Curran HV, Freeman TP. PMID: 35603918.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    28. Rating the comparative efficacy of state-level cannabis policies on recreational cannabis markets in the United States. Int J Drug Policy. 2022 08; 106:103744. Blanchette JG, Pacula RL, Smart R, Lira MC, Boustead AE, Caulkins JP, Kilmer B, Kerr WC, Treffers R, Naimi TS. PMID: 35636068.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    29. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study. Int J Drug Policy. 2022 07; 105:103716. Hammond D, Goodman S, Wadsworth E, Freeman TP, Kilmer B, Schauer G, Pacula RL, Hall W. PMID: 35613480.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    30. Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients. JAMA Netw Open. 2022 05 02; 5(5):e2211677. Lapham GT, Matson TE, Carrell DS, Bobb JF, Luce C, Oliver MM, Ghitza UE, Hsu C, Browne KC, Binswanger IA, Campbell CI, Saxon AJ, Vandrey R, Schauer GL, Pacula RL, Horberg MA, Bailey SR, McClure EA, Bradley KA. PMID: 35604691; PMCID: PMC9127557.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    31. Mental Health Conditions and Substance Use Disorders Among Youth Subsequently Diagnosed With Opioid Use Disorder or Opioid Poisoning. J Addict Med. 2022 May-Jun 01; 16(3):357-359. Agbese E, Stein BD, Druss BG, Dick AW, Pacula RL, Leslie DL. PMID: 34261890; PMCID: PMC8755850.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Impact of cannabis legalization on healthcare utilization for psychosis and schizophrenia in Colorado. Int J Drug Policy. 2022 06; 104:103685. Wang GS, Buttorff C, Wilks A, Schwam D, Tung G, Pacula RL. PMID: 35429874; PMCID: PMC9295869.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    33. Prices and Purchase Sources for Dried Cannabis Flower in the United States, 2019-2020. Cannabis Cannabinoid Res. 2023 10; 8(5):923-932. Wadsworth E, Driezen P, Pacula RL, Kilmer B, Hammond D. PMID: 35363550.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    34. Relationships of Cannabis Policy Liberalization With Alcohol Use and Co-Use With Cannabis: A Narrative Review. Alcohol Res. 2022; 42(1):06. Pacula RL, Smart R, Lira MC, Pessar SC, Blanchette JG, Naimi TS. PMID: 35360879; PMCID: PMC8936161.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    35. Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado. Prev Med. 2022 03; 156:106993. Wang GS, Buttorff C, Wilks A, Schwam D, Metz TD, Tung G, Pacula RL. PMID: 35150750; PMCID: PMC8956031.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    36. Correction to: Moving beyond the classic diferencein-diferences model: a simulation study comparing statistical methods for estimating efectiveness of state-level policies. BMC Med Res Methodol. 2022 Jan 30; 22(1):29. Grifn BA, Schuler MS, Stuart EA, Patrick S, McNeer E, Smart R, Powell D, Stein BD, Schell TL, Pacula RL. PMID: 35094676; PMCID: PMC8802410.
      View in: PubMed   Mentions:    Fields:    
    37. Comparison of hospital claims and poison center data to evaluate health impact of opioids, cannabis and synthetic cannabinoids. Am J Emerg Med. 2022 Mar; 53:150-153. Wang GS, Buttorff C, Wilks A, Schwam D, Tung GJ, Banerji S, Dart RC, Pacula RL. PMID: 35051702; PMCID: PMC8956045.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    38. Cannabis flower prices and transitions to legal sources after legalization in Canada, 2019-2020. Drug Alcohol Depend. 2022 02 01; 231:109262. Wadsworth E, Driezen P, Pacula RL, Hammond D. PMID: 34998249.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    39. The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic. Drug Alcohol Depend. 2022 02 01; 231:109232. Stein BD, Sheng F, Taylor EA, Dick AW, Sorbero M, Pacula RL. PMID: 35007956; PMCID: PMC8810626.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    40. APCDs can Provide Important Insights for Surveilling the Opioid Epidemic, With Caveats. Med Care Res Rev. 2022 08; 79(4):594-601. Buttorff C, Wang GS, Tung GJ, Wilks A, Schwam D, Pacula RL. PMID: 34933577; PMCID: PMC9252452.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    41. Moving beyond the classic difference-in-differences model: a simulation study comparing statistical methods for estimating effectiveness of state-level policies. BMC Med Res Methodol. 2021 12 13; 21(1):279. Griffin BA, Schuler MS, Stuart EA, Patrick S, McNeer E, Smart R, Powell D, Stein BD, Schell TL, Pacula RL. PMID: 34895172; PMCID: PMC8666265.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Assessment of State and Federal Health Policies for Opioid Use Disorder Treatment During the COVID-19 Pandemic and Beyond. JAMA Health Forum. 2021 11; 2(11):e213833. Pessar SC, Boustead A, Ge Y, Smart R, Pacula RL. PMID: 35647581; PMCID: PMC9138185.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    43. Assessment of Recreational Cannabis Dispensaries' Compliance With Underage Access and Marketing Restrictions in California. JAMA Pediatr. 2021 11 01; 175(11):1178-1180. Shi Y, Pacula RL. PMID: 34398218; PMCID: PMC8369376.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    44. Trends in Cannabis Involvement and Risk of Alcohol Involvement in Motor Vehicle Crash Fatalities in the United States, 2000‒2018. Am J Public Health. 2021 11; 111(11):1976-1985. Lira MC, Heeren TC, Buczek M, Blanchette JG, Smart R, Pacula RL, Naimi TS. PMID: 34709858; PMCID: PMC8630490.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    45. The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use. Addiction. 2022 06; 117(6):1510-1517. Lorenzetti V, Hindocha C, Petrilli K, Griffiths P, Brown J, Castillo-Carniglia Á, Caulkins JP, Englund A, ElSohly MA, Gage SH, Groshkova T, Gual A, Hammond D, Lawn W, López-Pelayo H, Manthey J, Mokrysz C, Pacula RL, van Laar M, Vandrey R, Wadsworth E, Winstock A, Hall W, Curran HV, Freeman TP. PMID: 34590359; PMCID: PMC9298052.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    46. Claims-based measures of prescription opioid utilization: A practical guide for researchers. Drug Alcohol Depend. 2021 11 01; 228:109087. Heins SE, Buttorff C, Armstrong C, Pacula RL. PMID: 34598101; PMCID: PMC8595838.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Changes in Emergency Department Encounters for Vomiting After Cannabis Legalization in Colorado. JAMA Netw Open. 2021 09 01; 4(9):e2125063. Wang GS, Buttorff C, Wilks A, Schwam D, Tung G, Pacula RL. PMID: 34533572; PMCID: PMC8449280.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    48. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. Int J Drug Policy. 2022 01; 99:103381. Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula RL, Rehm J, Room R, van den Brink W, Hall W. PMID: 34465496.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsPHPublic Health
    49. Commentary on Rychert and Wilkins (2021) 'Why did New Zealand's referendum to legalise recreational cannabis fail?' Drug Alcohol Rev. 2021 09; 40(6):884-885. Pacula RL. PMID: 34002906; PMCID: PMC9265243.
      View in: PubMed   Mentions:    Fields:    
    50. Trends in personal and family member opioid prescriptions prior to a diagnosis of an opioid-related problem among adolescents and young adults. Subst Abus. 2021; 42(4):483-486. Cohrs AC, Pacula RL, Dick AW, Stein BD, Druss BG, Leslie DL. PMID: 33797321; PMCID: PMC10695273.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    51. Current U.S. State Cannabis Sales Limits Allow Large Doses for Use or Diversion. Am J Prev Med. 2021 05; 60(5):701-705. Pacula RL, Blanchette JG, Lira MC, Smart R, Naimi TS. PMID: 33589301; PMCID: PMC8068584.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    52. Internet search and medicaid prescription drug data as predictors of opioid emergency department visits. NPJ Digit Med. 2021 Feb 11; 4(1):21. Young SD, Zhang Q, Zhou J, Pacula RL. PMID: 33574500; PMCID: PMC7878816.
      View in: PubMed   Mentions: 3  
    53. PROTOCOL: The effects of cannabis liberalization laws on health, safety, and socioeconomic outcomes: An evidence and gap map. Campbell Syst Rev. 2021 Mar; 17(1):e1137. Sevigny EL, Pacula RL, Aloe AM, Medhin DN, Greathouse J. PMID: 37050965; PMCID: PMC8356275.
      View in: PubMed   Mentions: 2  
    54. THE EVOLVING CONSEQUENCES OF OXYCONTIN REFORMULATION ON DRUG OVERDOSES. Am J Health Econ. 2021; 7(1):41-67. Powell D, Pacula RL. PMID: 34568515; PMCID: PMC8460090.
      View in: PubMed   Mentions: 14  
    55. Data Needs in Opioid Systems Modeling: Challenges and Future Directions. Am J Prev Med. 2021 02; 60(2):e95-e105. Jalali MS, Ewing E, Bannister CB, Glos L, Eggers S, Lim TY, Stringfellow E, Stafford CA, Pacula RL, Jalal H, Kazemi-Tabriz R. PMID: 33272714; PMCID: PMC8061725.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    56. The need to more effectively regulate END markets: A primary public health lesson of the U.S. vaping associated lung injury outbreak. Addiction. 2021 05; 116(5):994-995. Pacula RL. PMID: 32754924; PMCID: PMC9273308.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    57. The state of the science in opioid policy research. Drug Alcohol Depend. 2020 09 01; 214:108137. Schuler MS, Heins SE, Smart R, Griffin BA, Powell D, Stuart EA, Pardo B, Smucker S, Patrick SW, Pacula RL, Stein BD. PMID: 32652376; PMCID: PMC7423757.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    58. How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D. J Health Econ. 2020 05; 71:102286. Powell D, Pacula RL, Taylor E. PMID: 32193022; PMCID: PMC7231644.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    59. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations. Am J Drug Alcohol Abuse. 2019; 45(6):644-663. Smart R, Pacula RL. PMID: 31603710; PMCID: PMC6934162.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    60. State-Level Approaches to Expanding Pharmacists' Authority to Dispense Naloxone May Affect Accessibility-Reply. JAMA Intern Med. 2019 10 01; 179(10):1443. Abouk R, Pacula RL, Powell D. PMID: 31589265.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. The impacts of potency, warning messages, and price on preferences for Cannabis flower products. Int J Drug Policy. 2019 12; 74:1-10. Shi Y, Cao Y, Shang C, Pacula RL. PMID: 31382201; PMCID: PMC6893125.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    62. Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose. JAMA Intern Med. 2019 06 01; 179(6):805-811. Abouk R, Pacula RL, Powell D. PMID: 31058922; PMCID: PMC6503576.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    63. Abuse-Deterrent Opioids: The Authors Reply. Health Aff (Millwood). 2019 04; 38(4):696. Powell D, Alpert A, Pacula RL. PMID: 30933583.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C. Health Aff (Millwood). 2019 02; 38(2):287-294. Powell D, Alpert A, Pacula RL. PMID: 30715966.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCellsPHPublic Health
    65. Prevalence of Cannabis Use in Youths After Legalization in Washington State. JAMA Pediatr. 2019 02 01; 173(2):192-193. Dilley JA, Richardson SM, Kilmer B, Pacula RL, Segawa MB, Cerdá M. PMID: 30566196; PMCID: PMC6439594.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    66. Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids. Am Econ J Econ Policy. 2018 Nov; 10(4):1-35. Alpert A, Powell D, Pacula RL. PMID: 34326924; PMCID: PMC8317673.
      View in: PubMed   Mentions: 60  
    67. A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees. Subst Abus. 2018; 39(4):419-425. Stein BD, Dick AW, Sorbero M, Gordon AJ, Burns RM, Leslie DL, Pacula RL. PMID: 29932847; PMCID: PMC6309581.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    68. Cannabis and the Opioid Crisis. Cannabis Cannabinoid Res. 2018; 3(1):108-116. Piomelli D, Weiss S, Boyd G, Pacula RL, Cooper Z. PMID: 29789812; PMCID: PMC5931647.
      View in: PubMed   Mentions: 4     Fields:    
    69. Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis. Addiction. 2018 06; 113(6):1003-1016. Sarvet AL, Wall MM, Fink DS, Greene E, Le A, Boustead AE, Pacula RL, Keyes KM, Cerdá M, Galea S, Hasin DS. PMID: 29468763; PMCID: PMC5942879.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    70. Do medical marijuana laws reduce addictions and deaths related to pain killers? J Health Econ. 2018 03; 58:29-42. Powell D, Pacula RL, Jacobson M. PMID: 29408153; PMCID: PMC7867411.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    71. Marijuana buyers in the United States, 2010-2014. Drug Alcohol Depend. 2018 02 01; 183:34-42. Azofeifa A, Sherman LJ, Mattson ME, Pacula RL. PMID: 29223915.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017. Addiction. 2017 Dec; 112(12):2206-2216. Klieger SB, Gutman A, Allen L, Pacula RL, Ibrahim JK, Burris S. PMID: 28696583; PMCID: PMC5725759.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansPHPublic Health
    73. Did the dependent coverage expansion increase risky substance use among young adults? Drug Alcohol Depend. 2017 09 01; 178:556-561. Breslau J, Yu H, Han B, Pacula RL, Burns RM, Stein BD. PMID: 28732319; PMCID: PMC5584585.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Early Impacts of Marijuana Legalization: An Evaluation of Prices in Colorado and Washington. J Prim Prev. 2017 Jun; 38(3):221-248. Hunt P, Pacula RL. PMID: 28456861; PMCID: PMC5544434.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    75. Medical Marijuana and Marijuana Legalization. Annu Rev Clin Psychol. 2017 05 08; 13:397-419. Pacula RL, Smart R. PMID: 28482686; PMCID: PMC6358421.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    76. Building the data infrastructure to evaluate cannabis legalization. Addiction. 2017 07; 112(7):1140-1141. Kilmer B, Pacula RL. PMID: 28477353.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    77. Advancing knowledge on cannabis policy using evidence from North America. Int J Drug Policy. 2017 04; 42:36-38. Stevens A, Pacula RL. PMID: 28314644.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    78. Association of State Recreational Marijuana Laws With Adolescent Marijuana Use. JAMA Pediatr. 2017 02 01; 171(2):142-149. Cerdá M, Wall M, Feng T, Keyes KM, Sarvet A, Schulenberg J, O'Malley PM, Pacula RL, Galea S, Hasin DS. PMID: 28027345; PMCID: PMC5365078.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    79. Preventing, Identifying, and Treating Prescription Drug Misuse Among Active-Duty Service Members. Rand Health Q. 2017 Jan; 7(1):8. Pacula RL, Hunter SB, Ober AJ, Osilla KC, Vardavas R, Blanchard JC, DeVries D, Drabo EF, Leuschner KJ, Stewart W, Walters J. PMID: 29057158; PMCID: PMC5644774.
      View in: PubMed   Mentions:
    80. Understanding and learning from the diversification of cannabis supply laws. Addiction. 2017 Jul; 112(7):1128-1135. Kilmer B, Pacula RL. PMID: 27891693; PMCID: PMC5446799.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    81. Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment. JAMA. 2016 Sep 20; 316(11):1211-1212. Stein BD, Sorbero M, Dick AW, Pacula RL, Burns RM, Gordon AJ. PMID: 27654608; PMCID: PMC5257276.
      View in: PubMed   Mentions: 60     Fields:    
    82. A Systematic Review of the Prevention and Treatment of Prescription Drug Misuse. Mil Med. 2016 05; 181(5):410-23. Blanchard J, Hunter SB, Osilla KC, Stewart W, Walters J, Pacula RL. PMID: 27136647.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    83. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction. 2016 06; 111(6):973-80. Pacula RL, Jacobson M, Maksabedian EJ. PMID: 26687431; PMCID: PMC5216038.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    84. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013. Subst Abus. 2016; 37(1):63-9. Burns RM, Pacula RL, Bauhoff S, Gordon AJ, Hendrikson H, Leslie DL, Stein BD. PMID: 26566761; PMCID: PMC4801690.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    85. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties. Milbank Q. 2015 Sep; 93(3):561-83. Stein BD, Pacula RL, Gordon AJ, Burns RM, Leslie DL, Sorbero MJ, Bauhoff S, Mandell TW, Dick AW. PMID: 26350930; PMCID: PMC4567853.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    86. Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys. Lancet Psychiatry. 2015 Jul; 2(7):601-8. Hasin DS, Wall M, Keyes KM, Cerdá M, Schulenberg J, O'Malley PM, Galea S, Pacula R, Feng T. PMID: 26303557; PMCID: PMC4630811.
      View in: PubMed   Mentions: 127     Fields:    Translation:Humans
    87. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11. Health Aff (Millwood). 2015 Jun; 34(6):1028-34. Dick AW, Pacula RL, Gordon AJ, Sorbero M, Burns RM, Leslie D, Stein BD. PMID: 26056209; PMCID: PMC4743254.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    88. The price elasticity of demand for heroin: Matched longitudinal and experimental evidence. J Health Econ. 2015 May; 41:59-71. Olmstead TA, Alessi SM, Kline B, Pacula RL, Petry NM. PMID: 25702687; PMCID: PMC4417427.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    89. More choice in health insurance marketplaces may reduce the value of the subsidies available to low-income enrollees. Health Aff (Millwood). 2015 Jan; 34(1):104-10. Taylor EA, Saltzman E, Bauhoff S, Pacula RL, Eibner C. PMID: 25561650.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    90. Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J Policy Anal Manage. 2015; 34(1):7-31. Pacula RL, Powell D, Heaton P, Sevigny EL. PMID: 25558490; PMCID: PMC4315233.
      View in: PubMed   Mentions: 140     Fields:    Translation:HumansAnimals
    91. Words Can Be Deceiving: A Review of Variation Among Legally Effective Medical Marijuana Laws in the United States. J Drug Policy Anal. 2014 Dec; 7(1):1-19. Pacula RL, Hunt P, Boustead A. PMID: 25657828; PMCID: PMC4314612.
      View in: PubMed   Mentions: 47  
    92. Supply of buprenorphine waivered physicians: the influence of state policies. J Subst Abuse Treat. 2015 Jan; 48(1):104-11. Stein BD, Gordon AJ, Dick AW, Burns RM, Pacula RL, Farmer CM, Leslie DL, Sorbero M. PMID: 25218919; PMCID: PMC4420477.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    93. Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am J Public Health. 2014 Jun; 104(6):1021-8. Pacula RL, Kilmer B, Wagenaar AC, Chaloupka FJ, Caulkins JP. PMID: 24825201; PMCID: PMC4062005.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansPHPublic Health
    94. The effects of medical marijuana laws on potency. Int J Drug Policy. 2014 Mar; 25(2):308-19. Sevigny EL, Pacula RL, Heaton P. PMID: 24502887; PMCID: PMC4010875.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    95. Natural experiments in a complex and dynamic environment: the need for a measured assessment of the evidence. J Policy Anal Manage. 2014; 33(1):232-5. Pacula RL, Sevigny EL. PMID: 24358531; PMCID: PMC4051883.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    96. Why Changes in Price Matter When Thinking About Marijuana Policy: A Review of the Literature on the Elasticity of Demand. Public Health Rev. 2014; 35(2):1-18. Pacula RL, Lundberg R. PMID: 25642015; PMCID: PMC4310503.
      View in: PubMed   Mentions: 25     Fields:    
    97. Decomposing Racial Disparities in Prison and Drug Treatment Commitments for Criminal Offenders in California. J Legal Stud. 2014 Jan 01; 43(1):155-187. MacDonald J, Arkes J, Nicosia N, Pacula RL. PMID: 25382877; PMCID: PMC4219536.
      View in: PubMed   Mentions: 2  
    98. Marijuana liberalization policies: why we can’t learn much from policy still in motion. J Policy Anal Manage. 2014; 33(1):212-21. Pacula RL, Sevigny EL. PMID: 24358530; PMCID: PMC4051884.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    99. Tackling Problem Drug Use. Rand Health Q. 2012; 1(4):9. Cave J, Hunt P, Ismail S, Levitt R, Pacula RL, Rabinovich L, Rubin J, Weed K, Kilmer B. PMID: 28083216; PMCID: PMC4945258.
      View in: PubMed   Mentions:
    100. The U.S. Drug Policy Landscape: Insights and Opportunities for Improving the View. Rand Health Q. 2012; 2(3):2. Kilmer B, Caulkins JP, Pacula RL, Reuter PH. PMID: 28083261; PMCID: PMC4945234.
      View in: PubMed   Mentions: 1  
    101. An Epidemiological Model for Examining Marijuana Use over the Life Course. Epidemiol Res Int. 2012; 2012. Paddock SM, Kilmer B, Caulkins JP, Booth MJ, Pacula RL. PMID: 23236590; PMCID: PMC3518305.
      View in: PubMed   Mentions: 3  
    102. Response to commentaries. Addiction. 2012 May; 107(5):876-7. Caulkins JP, Kilmer B, Maccoun RJ, Pacula RL, Reuter P. PMID: 22471568.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    103. Bringing perspective to illicit markets: estimating the size of the U.S. marijuana market. Drug Alcohol Depend. 2011 Dec 01; 119(1-2):153-60. Kilmer B, Caulkins J, Pacula R, Reuter P. PMID: 22148148.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    104. Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19. Addiction. 2012 May; 107(5):865-71. Caulkins JP, Kilmer B, MacCoun RJ, Pacula RL, Reuter P. PMID: 21985069.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    105. Substance use and recessions: what can be learned from economic analyses of alcohol? Int J Drug Policy. 2011 Sep; 22(5):326-34. Pacula RL. PMID: 21855312.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    106. Addiction research centres and the nurturing of creativity. RAND's Drug Policy Research Center. Addiction. 2011 Feb; 106(2):253-9. Reuter P, Pacula RL, Caulkins JP. PMID: 20626722.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    107. An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California. J Drug Policy Anal. 2011 Feb; 4(1). Nunberg H, Kilmer B, Pacula RL, Burgdorf J. PMID: 23750291; PMCID: PMC3673028.
      View in: PubMed   Mentions: 61  
    108. Heterogeneity in the composition of marijuana seized in California. Drug Alcohol Depend. 2011 Aug 01; 117(1):59-61. Burgdorf JR, Kilmer B, Pacula RL. PMID: 21288662; PMCID: PMC3118261.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    109. Marijuana use and high school dropout: the influence of unobservables. Health Econ. 2010 Nov; 19(11):1281-99. McCaffrey DF, Pacula RL, Han B, Ellickson P. PMID: 19937639; PMCID: PMC2910149.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    110. RISKS AND PRICES: THE ROLE OF USER SANCTIONS IN MARIJUANA MARKETS. B E J Econom Anal Policy. 2010 Feb 17; 10(1). Pacula RL, Kilmer B, Grossman M, Chaloupka FJ. PMID: 23536916; PMCID: PMC3606926.
      View in: PubMed   Mentions: 16  
    111. The incremental inpatient costs associated with marijuana comorbidity. Drug Alcohol Depend. 2008 Jan 01; 92(1-3):248-57. Pacula RL, Ringel J, Dobkin C, Truong K. PMID: 17928166; PMCID: PMC2212669.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    112. Is the drug court model exportable? The cost-effectiveness of a driving-under-the-influence court. J Subst Abuse Treat. 2006 Jul; 31(1):75-85. Eibner C, Morral AR, Pacula RL, MacDonald J. PMID: 16814013.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    113. Racial differences in marijuana-users' risk of arrest in the United States. Drug Alcohol Depend. 2006 Oct 01; 84(3):264-72. Ramchand R, Pacula RL, Iguchi MY. PMID: 16600529.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    114. College students' use of cocaine. Subst Use Misuse. 2006; 41(4):489-509. Williams J, Pacula RL, Chaloupka FJ, Wechsler H. PMID: 16522560.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    115. Limits of current economic analyses of the demand for illicit drugs. Subst Use Misuse. 2006; 41(4):607-9. Williams J, Pacula RL, Chaloupka FJ, Wechsler H. PMID: 16522567.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    116. What does it mean to decriminalize marijuana? A cross-national empirical examination. Adv Health Econ Health Serv Res. 2005; 16:347-69. Pacula RL, MacCoun R, Reuter P, Chriqui J, Kilmer B, Harris K, Paoli L, Schäfer C. PMID: 17867248.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    117. What we can--and cannot--expect from school-based drug prevention. Drug Alcohol Rev. 2004 Mar; 23(1):79-87. Caulkins JP, Pacula RL, Paddock S, Chiesa J. PMID: 14965889.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    118. State medical marijuana laws: understanding the laws and their limitations. J Public Health Policy. 2002; 23(4):413-39. Pacula RL, Chriqui JF, Reichmann DA, Terry-McElrath YM. PMID: 12532682.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    119. The effects of macro-level interventions on addictive behavior. Subst Use Misuse. 2001 Dec; 36(13):1901-22. Pacula RL, Chaloupka FJ. PMID: 11795584.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    120. Does the sunset of mental health parity really matter? Adm Policy Ment Health. 2001 May; 28(5):353-69. Gitterman DP, Sturm R, Pacula RL, Scheffler RM. PMID: 11678068.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    121. Private insurance: what has parity brought. Behav Healthc Tomorrow. 2001 Apr; 10(2):SR26-8. Sturm R, Pacula RL. PMID: 12741050.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    122. Economics of youth drug use, addiction and gateway effects. Addiction. 2001 Jan; 96(1):151-64. Kenkel D, Mathios AD, Pacula RL. PMID: 11177526.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    123. Datapoints: mental health parity and employer-sponsored health insurance in 1999-2000: II. Copayments and coinsurance. Psychiatr Serv. 2000 Dec; 51(12):1487. Pacula RL, Sturm R. PMID: 11097639.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    124. Mental health parity and employer-sponsored health insurance in 1999-2000: I. limits. Psychiatr Serv. 2000 Nov; 51(11):1361. Sturm R, Pacula RL. PMID: 11058178.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    125. Mental health parity legislation: much ado about nothing? Health Serv Res. 2000 Apr; 35(1 Pt 2):263-75. Pacula RL, Sturm R. PMID: 10778814; PMCID: PMC1089100.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    126. Datapoints: labor force participation by persons with mental illness. Psychiatr Serv. 1999 Nov; 50(11):1407. Sturm R, Gresenz CR, Pacula RL, Wells KB. PMID: 10543847.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    127. State mental health parity laws: cause or consequence of differences in use? Health Aff (Millwood). 1999 Sep-Oct; 18(5):182-92. Sturm R, Pacula RL. PMID: 10495606.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    128. Sex and race differences in young people's responsiveness to price and tobacco control policies. Tob Control. 1999; 8(4):373-7. Chaloupka FJ, Pacula RL. PMID: 10629242; PMCID: PMC1759747.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    129. Does increasing the beer tax reduce marijuana consumption? J Health Econ. 1998 Oct; 17(5):557-85. Pacula RL. PMID: 10185512.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    130. Economic modelling of the gateway effect. Health Econ. 1997 Sep-Oct; 6(5):521-4. Pacula RL. PMID: 9353655.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Rosalie's Networks
    Concepts (258)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (14)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.